Send2Press Newswire › ROKiT Pharma Inc News Room and Media Kit

ROKiT Pharma Inc Newsroom - Profile and News Archive

ROKiT Pharma is a late stage preclinical pharma company focusing its research efforts on cancer. The corporation has an extensive global intellectual property portfolio. Research was developed at and in conjunction with the University of Sydney.

Engage with ROKiT Pharma Inc

Learn more online at: https://www.rokitpharma.com/

Follow:

RSS News Feed for ROKiT Pharma Inc

Press Releases from ROKiT Pharma Inc :

ROKiT Pharma’s Preclinical Studies Showing Tremendous Promise for Naturally Derived Cancer Drug, ROK-001 – Moving Towards The Initiation Of Phase 1b/2 Clinical Trial

Apr 2, 2020 6:00 AM EDT

LOS ANGELES, Calif., April 2, 2020 (SEND2PRESS NEWSWIRE) — ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.

Accessibility Adjustments

Accessibility Commitment for NEOTROPE dba Send2Press

At NEOTROPE dba Send2Press, we are committed to making our digital presence as accessible and inclusive as reasonably possible for all users, including individuals with disabilities. Our goal is to improve the usability of https://www.send2press.com/wire and to support a more accessible experience for everyone, regardless of their abilities or the technologies they use.

Our Approach to Accessibility

We aim to align with the Web Content Accessibility Guidelines (WCAG), which define internationally recognized standards for digital accessibility. While full compliance cannot always be guaranteed, we strive to implement improvements where feasible and regularly review accessibility-related aspects of our website. Accessibility is an ongoing process, and we are committed to improving the experience over time as technologies, standards, and user needs evolve.

Accessibility Features

To support accessibility, https://www.send2press.com/wire may utilize tools such as the accessibility toolbar. This interface provides users with a range of helpful features, including:

Adjustable text size and contrast settings
Highlighting of links and text for better visibility
Full keyboard navigation of the toolbar interface
Quick launch via keyboard shortcut: Alt + . (Windows) or ⌘ + . (Mac)

Please note the following:

The availability and effectiveness of these features depend on the website's configuration and ongoing maintenance.
While we strive to ensure accessibility, we cannot guarantee that every part of https://www.send2press.com/wire will be fully accessible at all times. Some content may be provided by third parties or affected by technical constraints beyond our immediate control.

Feedback and Contact

We welcome your feedback. If you experience any accessibility barriers or have suggestions for improvement, please contact us: Email: help@send2press.com We are committed to reviewing all inquiries and aim to respond within 3–5 business days. If you require assistance accessing any part of this website, we are happy to provide support through alternative channels upon request. Last updated: March 4, 2026

Select your accessibility profile

Vision Impaired Mode

Enhances website's visuals

Seizure Safe Profile

Clear flashes & reduces color

ADHD Friendly Mode

Focused browsing, distraction-free

Blindness Mode

Reduces distractions, improves focus

Epilepsy Safe Mode

Dims colors and stops blinking

Content Modules

Font Size

Default

Line Height

Default

Color Modules

Orientation Modules